It's a nice unexpected action these last few days. Super excited for the conference call!

Hey Smurf, have you looked at PMBS? It's always been a Ticker on my watch list. What do you think of its long term capability? Roughly 100 million shares outstanding..... Market cap less then 200 thousand.

Do you know a timeline for IGXT's resubmission?

I hope You and Ned have been doing well. I apologize for not posting much. I have a midterm every week for 7 weeks lol. I saw that IGXT got the CRL! I might look into that one. Just being cautious because the entire market has looked grim these past few months.

I'm thinking about selling soon. That's a nasty amount of money they're shelving.

Thanks for sending the email. So I guess if not today, then it has to be sometime next week. Oh well.

I also saw that date on my trading website too. At least it will be within a week lol.

I'm probably going to jump in BLUSF in Feb too. How much were you thinking about putting in? That market cap just seems way too attractive for what they have.

I think there were two separate dates posted as earning release days. Not sure which one it is. It was on the last day of January last year, which was a Thursday.

Hopefully they will give us details on the progress of their new drug launched and their Oxy program.

And now I just noticed to posted BLUSF on this board too.....
Damn, we do think alike. Lol sorry for all of these messages.

WAIT WTF? You're already looking at that stock aren't you? I just noticed you posting on their board?

What a freakin small world lol.

SMURF, I would appreciate if you took a look at this company too. I'm just starting to read up on it. Tell me what you think. This one is a long term home run potential from what I'm reading.



BLUSF-DD ..A FANTASTIC INVESTMENT TO MAKE BIG MONEY !!!


Just look at Volume and you will know that almost nobody knows this Monster Sleeping Giant with brutally upside potential means you have the opportunity to buy at the Bottom and before it hit the radar of investors .

Here is Why i like the Company so much :

1) Trading at Cash Level
2) Very Low Burn-Rate of $900k per Q (Cash untill Late 2017)
3) Strong Insider and Institutional Ownership (Holding 70% of the 47.3 M Share Outstanding )
4) KIACTA™ for AA Amyloidosis has Orphan Drug Status (NO approved Drugs for this Indication)
5) Previous Phase 3 of KIACTA™ was Successful and they just need the same results in the ongoing Phase 3 to get Approval
6) Great CEO who sold another Company for $4 B to Shire


Bellus Health (BLU.TO) (BLUSF)

Market Cap: $17.6 M
Cash: $16.3 M
Price: $0.41

Shares Outstanding: 47.4 M ( 70% of these Shares held by Insiders and Institutions)


New Slide Presentation ( Jan 2014)
http://www.bellushealth.com/files/doc_presentations/Bellus%20Corporate%20Presentation%20January%202014%20vFINAL.pdf


Interview with Ceo (November 2013)
http://watch.bnn.ca/#clip1047918


Interview
http://www.pharmaboardroom.com/article/interview-roberto-bellini-president-ceo-bellus-health-canada


BELLUS Health’s experienced clinical development team focuses on bringing compounds from the preclinical stage through clinical trials.

The Company’s lead program is KIACTA™, a novel drug candidate currently in a Phase III Confirmatory Study for the treatment of AA amyloidosis, an orphan indication resulting in renal dysfunction that often rapidly leads to dialysis and death. KIACTA™ is partnered with global private equity firm Auven Therapeutics. KIACTA™ peak annual revenues are projected at $400-600 million (U.S., EU5, Japan).

In addition to KIACTA™, BELLUS Health’s pipeline includes Shigamab™, an antibody treatment for Hemolytic Uremic Syndrome caused by Shiga toxin-producing E. coli ("sHUS"). Shigamab™ has recently completed a Phase II clinical trial.
-
Some key reasons to consider investing in BELLUS Health include:

Focus on rare diseases – pipeline of rare disease projects in areas of high unmet medical need

Late stage pipeline – global Phase III study for KIACTA™ currently enrolling patients

Fully funded business plan – strong balance sheet with cash runway that will meet funding requirements beyond 2017

Key shareholders –shareholder base with proven track record of building successful healthcare companies

----------------------------------------------------
KIACTA™ peak annual revenues projected at $500 million (Summary)


Strong Clinical Results in First Phase III Study
Landmark study in AA amyloidosis: 183 patients treated for 2 years

Important benefits for patients on drug:

Statistically significant reduction in number and risk of reaching
worsening kidney event

Important delay in reaching dialysis New England Journal of
Medicine publication concludes that KIACTA TM slows decline of renal function in AA amyloidosis

MARKET SIZE

Orphan drug designation granted with market protection in the U.S. (7years), Europe and Japan (10 years)
Formulation (Dosing Schedule) and Methods for Treating Amyloidosis with expiry in 2026 5 year patent extension can be applied to provide protection until 2031

MARKET PROTECTION

KIACTA™ peak annual revenues projected at $500 million Clear pharmacoeconomic
rationale due to high cost of kidney disease Premium pricing for comparative rare disease drugs

PARTNERSHIP

Partnership to fund Phase III Confirmatory Study with significant upside for BELLUS shareholders
With global fund Auven Therapeutics, a private equity group specialized in drug development project
financing Auven Therapeutics funding 100% of KIACTA™’s Phase III Confirmatory Study

FINANCIALS

US$10M in upfront by Auven Therapeutics
US$50M in investments by Auven Therapeutics
Proceeds of exit expected to be shared 50-50

I think that's about it for me at the moment lol. I'm in ELTP, IPCI , Mwip , CPRX , Hznp , and Ig

Haha I've been in MWIP since 2011.

Yep. Nothing goes straight up. Our RSI is back down to 70. Setting up for the next run.

Entire Bio market is getting hit hard today.

Elite would need a 48 billion market cap at $100.

Very unlikely.

Now if everything lined up perfectly for Elite, then $20 is highly possible.

Well that ruined it for me... lol.

Thanks for ruining the mood Hike.

Hahah.

Minor off topic response to the posting.

The posting on the website looks like a 2014 website posting, not the retro style of the website itself. May be a sign of updating the website soon.

Just wanted to mention that.

Good morning Pedro!
We'll find out in a few weeks if they've diluted or not.

Well they can't hold back bad results and wait out for good ones..... That's flat out illegal. I know the trial was smaller compared to others, but I'm sure they're not rushing the process.

Haha you have a good weekend Ray.

Glad to hear that we have a team of young guns here as Elite longs.

I think every other company in the stock market had dilution today! :O

Elite started the day down over 10% and has quickly recovered into positive territory. RSI at 81 now.

Been here since 2011.

It's a freezing market day. I just saw PVCT and their selloff yesterday, what the heck happened there?

Wasn't that Honk Kong partnership PR on a Friday? It was a while back, so don't quote me on it lol.

Haha well when/if they get a few of their Abuse Resistant drugs, this will hit $10+ with a conservative 15 P/E . CEO told investors at the Piper Conference.

IGXT was always one of this stocks I looked at and never got in lol. I regret it. Congrats on your gains !

Made some good gains today! How's your portfolio doing today?

Haha thank you Z! My .06 cent purchases over summer are paying off! I'm holding on for a few years though. Are you trading it or holding?

I've been following Synthetic Bio since they were named something else lol. I haven't been keeping up with their financials. I check into it after class.

ELTP having a monster day today!

CPRX is finally getting their deserved breakout!

Any other picks that you have been keeping track of?

Gosh Couch, those Summer purchases sure are paying elegant dividends aren't they?

Thanks Ned. I definitely value your input and will keep watch.

Haha today is great! You're up huge too! Good job on buying! I'm happy for us!

Something must have. Curious to see how it unfolds. Congrats on your gains today! I'm a little delusional seeing how much I'm up on this stock haha.

Man I woke up to see my account skyrocket ! It's up 32%! I never imagined having this much mullah as a Junior in college lol.

Good morning Doc. Real surprised to see this explode. Puts a really smile on my face. Hopefully we close above .30!